The Risk-Benefit Paradigm vs the Causal Exposure Paradigm: LDL as a primary cause of vascular disease

Area of Science:

• Cardiovascular Medicine
• Preventive Cardiology
• Pharmacology

Background:

• Current guidelines for statin primary preventive therapy rely on a 10-year cardiovascular event risk assessment.
• Statin initiation is typically based on achieving a specified risk threshold, adhering to a Risk-Benefit paradigm.
• Recent guidelines increasingly emphasize risk, with exceptions for markedly elevated low-density lipoprotein cholesterol (LDL-C).

Purpose of the Study:

• To compare the strengths and weaknesses of the Risk-Benefit and Causal Exposure paradigms in cardiovascular disease prevention.
• To provide a framework for evaluating different cholesterol guidelines.
• To emphasize the relationship between low-density lipoprotein (LDL) levels, cardiovascular risk, and statin therapy benefits.

Main Methods:

• Comparative analysis of the Risk-Benefit and Causal Exposure paradigms in primary prevention.
• Review of evidence linking LDL cholesterol levels to cardiovascular risk and statin efficacy.
• Evaluation of current cholesterol guidelines based on the discussed paradigms.

Main Results:

• The Risk-Benefit paradigm focuses on the probability of future events.
• The Causal Exposure paradigm targets the underlying arterial disease caused by risk factors like LDL.
• Evidence suggests cardiovascular risk and statin benefit are directly related to LDL cholesterol levels.

Conclusions:

• The Causal Exposure paradigm offers a different perspective on cardiovascular disease prevention by addressing the root cause.
• Understanding both paradigms is crucial for a comprehensive evaluation of statin therapy guidelines.
• The level of LDL cholesterol is a critical factor influencing both disease progression and treatment effectiveness.